Results 191 to 200 of about 51,241 (251)
Clinical Outcomes of Intravenous Thrombolysis in Acute Ischemic Stroke: A Prospective Observational Study From Mumbai. [PDF]
CureusSolapure V, Gore S, Shah K, Shah P.
europepmc +1 more source
Association Between Free Triiodothyronine to Free Thyroxine Ratio and Hemorrhagic Transformation After Intravenous Thrombolysis in Acute Ischemic Stroke Patients. [PDF]
Brain BehavMa H, Li H, Fu X, Wei C, Ma A.
europepmc +1 more source
Comparative effectiveness and safety of tenecteplase versus alteplase for intravenous thrombolysis in acute ischemic stroke: a retrospective study. [PDF]
Front NeurolZhao W, Zhang X, Zhao Y, Zhao R, Liu Y.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Cystatin C and intravenous thrombolysis
European Journal of Neurology, 2021With great interest, we read the recent original article written by Zihan Chang et al1 , which was published in European Journal of Neurology. In this multicenter retrospective case-control study, the authors found that elevated serum Cystatin C may be associated with unfavorable clinical outcomes after intravenous tissue plasminogen activator therapy,
Meidi Peng, Yupei Chen, Guiling Geng
openaire +2 more sources
Beyond Intravenous Thrombolysis
CNS Spectrums, 2007ABSTRACTThe National Institute of Neurological Disorders and Stroke trial of recombinant tissue plasminogen activator has been considered a landmark study in the acute treatment of ischemic stroke. Unfortunately, only a small percentage of all ischemic stroke patients presents to the hospital in time to receive the drug.
Kiwon, Lee +5 more
openaire +2 more sources